Skip to main content

Closed

XRTX: XORTX Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-238.9%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio0.43×

XORTX Therapeutics Inc.

XRTXNASDAQ Capital Market·USD·Closed

XORTX Therapeutics Inc.

XRTXNASDAQ·USD·Closed

$2.12

+4.95%

$2.12

+$0.10 (4.95%)

52W Range

7thpctl

Volume

0.32×avg

Mkt Cap

590397USD

P/E

-0.2TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.32×avg

Market Cap

590397USD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings